NB3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neurocrine Biosciences Inc

Watchlist Manager

Watchlist

Price: 115.25 EUR 0.79% Market Closed

Market Cap: €6.5B

N	Neurocrine Biosciences Inc SWB:NB3	US
	Edison Opto Corp TWSE:3591	TW
S	Sartorius AG XHAM:SRT	DE
	International Stem Cell Corp OTC:ISCO	US
	EVN AG F:EVN	AT
	Borregaard ASA F:BO4	NO
	Sony Group Corp LSE:0L83	JP
M	Micron Technology Inc F:MTE	US
R	Rapala VMC Oyj XBER:RAP	FI
S	Sherwin-Williams Co LSE:0L5V	US

Profitability Summary

Neurocrine Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

98% > 98%

Healthy Operating Margin

26%

Sustainable 3Y Average Operating Margin

22%

Operating Margin is Increasing

17% > 26%

Healthy Net Margin

22%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

4% > 22%

Exceptional Free Cash Flow Margin

27%

Strong 3Y Average Free Cash Flow Margin

23%

Free Cash Flow Margin is Increasing

15% > 27%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

22%

ROIC is Increasing

17% > 20%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.